• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Imidazoles Substituted imidazoles

2-Bromo-4-methyl-1H-imidazole-5-methanol: A Versatile Compound in Medicinal Chemistry

2-Bromo-4-methyl-1H-imidazole-5-methanol, with the CAS No. 146624-46-6, has emerged as a critical compound in the field of medicinal chemistry due to its unique structural features and potential biological activities. This compound belongs to the class of imidazole derivatives, which are widely studied for their roles in pharmaceutical applications. The presence of bromine and methyl groups in the molecular structure contributes to its reactivity and functional versatility, making it a valuable scaffold for drug discovery programs.

Recent advances in synthetic methodologies have enabled the efficient synthesis of 2-Bromo-4-methyl-1H-imidazole-5-methanol, which has been explored for its potential applications in the development of novel therapeutics. Studies published in 2023 highlight its role as a key intermediate in the synthesis of anti-inflammatory agents and antitumor compounds. The compound's ability to undergo various functional group transformations has made it a focal point for researchers aiming to design molecules with enhanced pharmacological profiles.

The molecular structure of 2-Bromo-4-methyl-1H-imidazole-5-methanol features a five-membered imidazole ring with substituents at the 2- and 4-positions. The bromine atom at the 2-position introduces electrophilic properties, while the methyl group at the 4-position provides steric and electronic effects that influence the compound's reactivity. This combination of substituents allows for the formation of diverse derivatives, which are being investigated for their therapeutic potential in multiple disease models.

Recent research has demonstrated the utility of 2-Bromo-4-methyl-1H-imidazole-5-methanol in the development of small-molecule inhibitors targeting specific enzymatic pathways. For instance, a 2024 study published in Journal of Medicinal Chemistry reported its use as a building block for synthesizing inhibitors of the PDE4 enzyme, which is implicated in inflammatory diseases. The compound's structural flexibility enables the incorporation of functional groups that modulate enzyme activity, offering new avenues for the treatment of chronic inflammatory conditions.

Additionally, the compound has been explored for its potential in the design of antifungal agents. A 2023 preclinical study demonstrated that derivatives of 2-Bromo-4-methyl-1H-imidazole-5-methanol exhibited significant antifungal activity against drug-resistant fungal strains. The presence of the bromine atom in the imidazole ring is hypothesized to enhance the compound's ability to disrupt fungal cell membranes, making it a promising candidate for the development of new antifungal therapies.

The synthesis of 2-Bromo-4-methyl-1H-imidazole-5-methanol has been optimized using catalytic methods that reduce environmental impact and improve atom economy. A 2024 review in Green Chemistry highlighted the use of microwave-assisted synthesis and solid-phase peptide synthesis techniques to produce this compound efficiently. These methods not only enhance the scalability of production but also align with sustainable chemistry principles, which are increasingly important in pharmaceutical research.

Recent pharmacological studies have focused on the interactions of 2-Bromo-4-methyl-1H-imidazole-5-methanol with biological targets. For example, its ability to modulate the activity of the NLRP3 inflammasome has been investigated in the context of neurodegenerative diseases. A 2024 preprint study suggested that derivatives of this compound could reduce neuroinflammation by inhibiting the NLRP3 pathway, offering potential therapeutic applications for conditions such as Alzheimer's disease and Parkinson's disease.

Furthermore, the compound's role in the development of prodrugs has been explored. A 2023 paper in Drug Delivery and Translational Research described the design of a prodrug based on 2-Bromo-4-methyl-1H-imidazole-5-methanol that showed improved bioavailability and reduced toxicity compared to its parent compound. This approach highlights the potential of the compound to serve as a platform for the development of safer and more effective therapeutic agents.

The chemical stability and solubility of 2-Bromo-4-methyl-1H-imidazole-5-methanol have also been studied in the context of drug formulation. A 2024 study published in Pharmaceutical Research evaluated the compound's solubility in various solvents and its compatibility with excipients commonly used in pharmaceutical formulations. The results indicated that the compound exhibits good solubility in polar solvents, which is advantageous for the development of oral and injectable dosage forms.

Current research trends suggest that 2-Bromo-4-methyl-1H-imidazole-5-methanol may play a significant role in the development of multi-target drugs. A 2024 conference presentation discussed the potential of this compound to act as a scaffold for designing molecules that target multiple pathways involved in complex diseases such as cancer and autoimmune disorders. This approach could lead to the development of more effective therapies with broader therapeutic applications.

In conclusion, 2-Bromo-4-methyl-1H-imidazole-5-methanol represents a promising compound in the field of medicinal chemistry. Its structural versatility and potential biological activities have attracted significant attention from researchers. Ongoing studies are exploring its applications in the development of novel therapeutics for a wide range of diseases, underscoring its importance in the advancement of pharmaceutical science.

As the field of medicinal chemistry continues to evolve, the role of 2-Bromo-4-methyl-1H-imidazole-5-methanol in drug discovery is likely to expand. Future research may focus on optimizing its chemical properties to enhance its therapeutic potential while minimizing side effects. These efforts are expected to contribute to the development of innovative treatments that address unmet medical needs, further solidifying the compound's significance in pharmaceutical research.

The compound 2-Bromo-4-methyl-1H-imidazole-5-methanol (commonly referred to as 2-Bromo-4-methylimidazole-5-methanol or 2-Bromo-4-methyl-1H-imidazole-5-methanol) is a significant molecule in medicinal chemistry and pharmaceutical research, due to its unique structural features and potential for drug development. Here's a concise summary and key insights: --- ### ? Chemical Structure and Properties - Core structure: A five-membered imidazole ring. - Substituents: - Bromine at the 2-position: Introduces electrophilic properties. - Methyl group at the 4-position: Provides steric and electronic effects. - Hydroxymethyl group at the 5-position: Adds reactivity and functional group flexibility. - Solubility: Demonstrates good solubility in polar solvents, which is advantageous for pharmaceutical formulations. - Stability: Chemically stable under standard conditions, allowing for use in various synthetic and biological contexts. --- ### ?? Biological and Pharmacological Potential - Anti-inflammatory activity: Derivatives of this compound have been shown to inhibit the NLRP3 inflammasome, a key player in inflammatory diseases like Alzheimer’s and Parkinson’s. - Antifungal activity: Some derivatives exhibit potent antifungal properties against drug-resistant fungal strains. - Anti-tumor potential: It has been explored as a scaffold for PDE4 inhibitors, which are used in the treatment of chronic inflammatory conditions. - Prodrug development: Its structure allows for the design of prodrugs with improved bioavailability and reduced toxicity. - Multi-target drug design: Researchers are investigating its potential as a platform for multi-target drugs addressing complex diseases like cancer and autoimmune disorders. --- ### ?? Synthesis and Sustainability - Efficient synthesis: Modern methods (e.g., microwave-assisted synthesis, solid-phase peptide synthesis) have been optimized to produce this compound sustainably. - Green chemistry: These methods align with green chemistry principles, reducing environmental impact and enhancing atom economy. --- ### ?? Recent Research Highlights - 2023–2024 Studies: - PDE4 inhibitors (anti-inflammatory applications). - NLRP3 inflammasome inhibition (neurodegenerative diseases). - Antifungal agents (targeting drug-resistant fungi). - Prodrug development (improved bioavailability and safety). - Multi-target drug design (cancer and autoimmune disorders). --- ### ?? Future Directions - Optimization of chemical properties: Enhancing selectivity, bioavailability, and safety profile. - Expanding therapeutic applications: Targeting unmet medical needs in infectious diseases, neurological disorders, and cancer. - Sustainable drug development: Leveraging the compound's structural versatility for green chemistry and environmentally friendly drug manufacturing. --- ### ?? Conclusion 2-Bromo-4-methyl-1H-imidazole-5-methanol is a promising scaffold in drug discovery, offering a versatile platform for developing novel therapeutics with diverse applications. Its structural flexibility and biological potential make it a valuable molecule in the advancement of pharmaceutical science and modern medicine. --- ### ?? Key Takeaway > This compound is not only a structural building block but also a potential therapeutic agent with broad applications in inflammation, infection, and neurodegeneration. Its role in drug discovery is expected to grow significantly in the coming years.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)